Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of concomitant medications affecting lamotrigine blood levels
jRCT1061220093Recruiting
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of lamotrigine in bipolar disorder (BD) and epilepsy (2 arms). Primary endpoint: Effect of UGT-inhibiting concomitant drugs on lamotrigine exposure. Started Feb 2023; status: recruiting.
02
Drugs
lamotrigine
03
Conditions
bipolar disorder (BD)epilepsy
Beyond the preview
Go deeper on jRCT1061220093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1061220093.